| 中文名称: | 缬沙坦杂质SJ |
| 中文别名: | N-[[2'(-(1H-四唑-5-基)[1,1'(-联苯]-4-基]甲基]-L-缬氨酸;缬沙坦去valeryl杂质;缬沙坦杂质;去(氧代戊基)缬沙坦;缬沙坦杂质/去(氧代戊基)缬沙坦 |
| smiles: | CC(C)C(C(=O)O)NCC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3 |
| 英文名称: | ((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-L-valine |
| 英文别名: | Des-N-(1-Oxopentyl) Valsartan;((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-L-valine;Des(oxopentyl) Valsartan;(S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)amino)butyric acid;(S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid;N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine;Devaleryl Valsartan Impurity;Valsartan Desvaleryl Impurity/Des(oxopentyl) Valsartan;CS-0131990;CS-0131990;CS-0131990;CS-0131990;(2S)-3-methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methylamino]butanoic Acid;(2S)-3-methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methylamino]butanoic Acid;(2S)-3-methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methylamino]butanoic Acid;(2S)-3-methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methylamino]butanoic Acid;MS-25438;MS-25438;MS-25438;MS-25438;MUB5LGF6FX;MUB5LGF6FX;MUB5LGF6FX;MUB5LGF6FX;(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoicacid;(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoicacid;(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoicacid;(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoicacid;1ST10159;1ST10159;1ST10159;1ST10159;L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;(S)-3-methyl-2-((2'-(1 H-tetrazol-5-yl)-biphenyl-4-ylmethyl)amino)-butyric acid;(S)-3-methyl-2-((2'-(1 H-tetrazol-5-yl)-biphenyl-4-ylmethyl)amino)-butyric acid;(S)-3-methyl-2-((2'-(1 H-tetrazol-5-yl)-biphenyl-4-ylmethyl)amino)-butyric acid;(S)-3-methyl-2-((2'-(1 H-tetrazol-5-yl)-biphenyl-4-ylmethyl)amino)-butyric acid;676129-92-3;676129-92-3;676129-92-3;676129-92-3;(S)-3-Methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid;(S)-3-Methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid;(S)-3-Methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid;(S)-3-Methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid;Desvaleryl Valsartan;Desvaleryl Valsartan;Desvaleryl Valsartan;Desvaleryl Valsartan;NSXSCTCKWRSTHJ-KRWDZBQOSA-N;NSXSCTCKWRSTHJ-KRWDZBQOSA-N;NSXSCTCKWRSTHJ-KRWDZBQOSA-N;NSXSCTCKWRSTHJ-KRWDZBQOSA-N;(2S)-3-Methyl-2-[[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Despentanoylvalsartan);(2S)-3-Methyl-2-[[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Despentanoylvalsartan);(2S)-3-Methyl-2-[[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Despentanoylvalsartan);(2S)-3-Methyl-2-[[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Despentanoylvalsartan);L-Valine, N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]... |
| CAS号: | 676129-92-3 |
| 分子式: | C19H21N5O2 |
| 分子量: | 351.40 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
缬沙坦杂质SJ
英文名:
((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-L-valine
别名:N-[[2'(-(1H-四唑-5-基)[1,1'(-联苯]-4-基]甲基]-L-缬氨酸;缬沙坦去valeryl杂质;缬沙坦杂质;去(氧代戊基)缬沙坦;缬沙坦杂质/去(氧代戊基)缬沙坦
商品编号:R216349-10mg
规格:10mg
纯度:分析对照品, 98%
CAS号: 676129-92-3
分子式:C19H21N5O2
分子量:351.40
| 价格 |
¥ 1123.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















